关于开发一个工具 (INSPECT-SR) 的协议,用于在对健康干预的系统审查中识别有问题的随机对照试验
Jack Wilkinson1, Calvin Heal2, George A Antoniou3,4
1Centre for Biostatistics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK jack.wilkinson@manchester.ac.uk.
一个新的工具INSPECT-SR正在开发中,用于在系统性审查中识别不可靠的随机对照试验 (RCT). 这旨在通过防止伪造或虚假数据在医学研究中的影响来改善医疗保健决策.
科学领域:
- 临床试验方法论 临床试验方法论
- 证据综合 证据综合
- 研究诚信研究诚信
背景情况:
- 随机对照试验 (RCT) 对于医疗保健决策至关重要.
- 关于已发表的RCT中存在伪造或虚假数据的存在存在存在担忧.
- 综合RCT的系统性审查通常不评估数据的可靠性,允许有问题的研究影响结论.
研究的目的:
- 开发一个工具,INSPECT-SR,用于在系统审查中评估RCT的可信度.
- 通过识别和排除含有虚假或伪造数据的研究来提高系统审查的可靠性.
- 保护患者免受基于错误研究的潜在有害医疗保健决策.
主要方法:
- INSPECT-SR工具将通过一个五阶段的过程来开发.
- 专家的共识将通过调查和共识会议收集.
- 经验证据将被用于完善对有问题的RCT的检查.
- 该工具将在系统审查中进行前性测试,以获得用户反和改进.
主要成果:
- 开发过程包括专家调查,可行性评估,德尔菲调查,共识会议和前性测试.
- 该项目旨在创建一个全面的检查清单,以检测有问题的RCT.
- 最终的工具将根据其在现实世界的系统审查中应用的反来改进.
结论:
- 预计INSPECT-SR工具将大大帮助研究人员识别不可靠的研究.
- 通过提高系统审查的质量,该工具将有助于更可靠的医疗保健证据.
- 该项目强调了基于证据的医学和患者护理中研究诚信的重要性.
更多相关视频
06:05The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
08:36The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
Published on: April 19, 2024
相关概念视频
Randomized Experiments
Simple randomization
Simple...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Hazard Ratio
For example, in a clinical trial evaluating a...
